MAKSIM MAMONKIN to Immunotherapy
This is a "connection" page, showing publications MAKSIM MAMONKIN has written about Immunotherapy.
Connection Strength
0.172
-
[CAR T-cell therapy: Balance of efficacy and safety]. Mol Biol (Mosk). 2017 Mar-Apr; 51(2):274-287.
Score: 0.096
-
Targeting IDH2R140Q and other neoantigens in acute myeloid leukemia. Blood. 2024 04 25; 143(17):1726-1737.
Score: 0.040
-
Engineering naturally occurring CD7- T cells for the immunotherapy of hematological malignancies. Blood. 2022 12 22; 140(25):2684-2696.
Score: 0.036